You need to be logged in to view this video

Earlier this month, GW Pharmaceuticals reshaped the way many people view cannabis when the company reported positive Stage 3 Clinical data for its Epidiolex product. For thousands of years, people all over the world used cannabis for a medicine. During this topic, Michael Berger, President of, will discuss how cannabis could shake up the pharmaceutical industry through the development of less harmful treatments for various illnesses.
Michael Berger
Duration: 22:55